Global Hematopoietic Stem Cell Transplantation Market: Overview
Hematopoietic stem cells (HSCs) are present in the bone marrow and blood. They are also known as hematopoietic progenitor cells (HPCs). Hematopoietic stem cells are capable of producing mature blood cells, such as platelets, white blood cells, and red blood cells. These cells are used in the treatment of different types of malignant diseases (e.g. lymphoma, leukemia) and non-malignant (e.g. hemoglobinopathies, bone marrow failure) to rebuild or replace a patient’s hematopoietic system.
Read Report Overview – https://www.transparencymarketresearch.com/hematopoietic-stem-cell-transplantation-hsct-market.html
This type of treatment is known as stem cell transplant or bone marrow transplant. Hematopoietic stem cells have also been used in clinical trials with U.S. FDA oversight for the treatment of genetic diseases, autoimmune diseases, and other indications.
Over the last 30 years, the hematopoietic stem cells transplantation market has seen a rapid and constant expansion with advancements in lifesaving technologies. Hematopoietic stem cell transplantation brings about restoration of the patient’s medullary and immune function while treating a diverse range of about 70 non-hematological and hematological disorders. Overall, hematopoietic stem cells transplantation is used in the treatment of immunological, oncological, non-malignant, hematological, malignant, and hereditary diseases.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=62316
There are two types of stem cell transplants: allogeneic and autologous. Allogeneic HSCT involves the replacement of diseased or damaged cells with cells from a healthy donor. The donor’s tissue type needs to match the receiver’s tissue type as closely as possible to help prevent the risk of problems with the transplant. Allogeneic transplantation is used for therapeutic intervention of patients with hematological disorders (cancerous or non-cancerous).
Autologous HSCT replaces diseased or damaged cells with the patient’s own stem cells. Harvesting of a patient’s stem cells is done before chemotherapy, and harvested stem cells are then transplanted back into the patient after treatment. Based on the source of hematopoietic stem cells, there are three types of HSCTs: cord blood transplant, peripheral blood stem cell transplant, and bone marrow transplant (BMT).
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=62316
Global Hematopoietic Stem Cell Transplantation Market: Key Trends
The global hematopoietic stem cell transplantation market is expected to expand at a rapid pace, due to a rise in the prevalence of hematopoietic disorders, increase in success rates of transplantation, and increase in the aging population across the world. According to a research report by the Scientific America, transplantation rates over the globe have increased from 50,000 HSC transplants per year in 2012 to 75,000 HSC transplants per year in 2015. However, high cost of transplantation and lack of funding for organizations such as the Worldwide Network for Blood & Marrow Transplantation (WBMT) are expected to restrain the global hematopoietic stem cell transplantation market during forecast period.
Global Hematopoietic Stem Cell Transplantation Market: Segmentation
The global hematopoietic stem cell transplantation market can be segmented based on disease indication, transplant, application, and region. In terms of disease indication, the market can be classified into leukemia, lymphoproliferative disorders, and non-malignant disorders. Based on transplant, the global hematopoietic stem cell transplantation market can be categorized into autologous and allogeneic. Allogeneic transplant is projected to continue to hold a dominant market share in terms of revenue during the forecast period, due to the high average cost of allogeneic transplants as compared to that of autologous transplants. In terms of application, the market can be segmented into cord blood transplants, peripheral blood stem cells transplants, and bone marrow transplants.
Pre Book Hematopoietic Stem Cell Transplantation Hsct Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=62316<ype=S
Global Hematopoietic Stem Cell Transplantation Market: Regional Analysis
Based on region, the global hematopoietic stem cell transplantation market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Europe is projected to lead the global market during the forecast period. The region’s dominance is attributed to the overall increase in success rate of transplants, easy technological applications, and high income of the population.
Global Hematopoietic Stem Cell Transplantation Market: Competitive Landscape
Key players operating in the global hematopoietic stem cell transplantation market include Escape Therapeutics, Lonza Group, Regen BioPharma Inc, Cesca Therapeutics Inc., Cryo-Save AG, CBR Systems, Inc., Pluristem Therapeutics Inc., China Cord Blood Corporation, and ViaCord Inc.
More Trending Reports by Transparency Market Research –
Heel Incision Devices Market: https://www.biospace.com/article/heel-incision-devices-market-hospitals-and-specialty-clinics-to-be-highly-attractive-end-user/
Hemophilia Treatment Drugs Market: https://www.biospace.com/article/fda-approvals-of-newer-drugs-bodes-well-for-hemophilia-treatment-drugs-market/
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
